NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-034-1994-2-PCT-01 PEPTOMERS WITH ENHANCED IMMUNOGENICITY PCT PCT COMB PCT/US1995/000760 Expired
NCI E-062-1995-0-US-01 IMMUNOTOXIN-MEDIATED CONDITIONAL DISRUPTION OF SPECIFIC NEURONS IN TRANSGENIC MICE US ORD 08/375,113 Abandoned
NCI E-013-1994-0-PCT-02 Protein Tyrosine Kinase A6 PCT PCT PCT/US1995/000601 Expired
NINDS E-106-1995-0-US-01 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY US ORD 08/371,530 Abandoned
NCI E-094-1994-0-US-01 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)c US ORD 08/373,934 7070972 Expired PDF
NIEHS E-009-1994-0-US-01 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same US ORD 08/372,183 6005086 Expired PDF
NCI E-217-1994-0-US-01 CONFORMATIONALLY CONSTRAINED DIACYLGLYCEROL ANALOGUES US ORD 08/372,602 5874464 Abandoned PDF
NCI E-023-1994-0-PCT-02 DIASTEREOSELECTIVE PROCESS LEADING TO A KEY INTERMEDIATE FOR THE PREPARATION OF FLUORINATED REVERSE TRANSCRIPTASE INHIBITORS PCT PCT PCT/US1995/000527 Expired
NCI E-137-1995-0-US-01 RECOMBINANT POXVIRUS-HTLV, COMPOSITIONS AND USES RELATED APPLICATIONS US CIP 08/372,664 Expired
NCI E-057-1994-1-US-01 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US ORD 08/370,909 5843648 Expired PDF
NCI E-054-1995-0-US-01 SYSTEM AND METHOD FOR SIMULATING A TWO-MULTIDIMENSIONAL RADIATION INTENSITY DISTRIBUTION OF PHOTON OR ELECTRON BEAMS US ORD 08/368,589 5526395 Expired PDF
NCI E-179-1992-0-US-02 HTS-1 GENE, A HUMAN TUMOR SUPPRESSOR GENE US FWC 08/369,043 5491064 Expired PDF
NCI E-160-1992-0-US-03 SUBSTRATE FOR THE EPIDERMAL GROWTH FACTOR RECEPTOR KINASE, ANTIBODIES THERETO AND METHODS OF USE THEREOF (eps8) US DIV 08/368,079 5610018 Expired PDF
NEI E-185-1992-3-US-01 PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION GENOMIC ORGANIZATION AND SEQUENCE OF THE PEDF GENE US CIP 08/367,841 6319687 Expired PDF
NIAID E-055-1991-0-US-03 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA US FWC 08/365,997 5853739 Expired PDF
NIEHS E-003-1991-0-US-07 HUMAN LACTOFERRIN US FWC 08/366,006 Abandoned
NCI E-201-1994-1-US-02 DIMERIC ARYLISOQUINOLINE ALKALOID COMPOUNDS US CON 08/363,684 5578729 Abandoned PDF
NIDDK E-058-1992-1-US-01 SPECTROSCOPIC IMAGING DEVICE EMPLOYING IMAGING QUALITY SPECTRAL FILTERS US CIP 08/363,363 5528368 Expired PDF
NCI E-196-1990-0-US-22 METHOD FOR DIAGNOSING TUMORS USING MOUSE MONOCLONAL ANTIBODIES US FWC 08/363,203 5612032 Abandoned PDF
NCI E-004-1990-0-US-08 ANTI-VIRAL COMPOUNDS AND THEIR USES US FWC 08/362,760 Abandoned
NCI E-051-1994-2-EP-04 USE OF MONOCLONAL ANTIBODIES OR SOLUBLE OLIGOMERIC LIGANDS IN THE MANUFACTURE OF A MEDICAMENT FOR THE PREVENTION OR TREATMENT OF NEOPLASTIC DISORDERS EP National Stage 95906686.1 Expired
NCI E-051-1994-2-AT-09 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 AT EP 95906686.1 Expired
NCI E-051-1994-2-BE-10 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 BE EP 95906686.1 Expired
NCI E-051-1994-2-DE-12 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 DE EP 95906686.1 Expired
NCI E-051-1994-2-DK-21 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 DK EP 95906686.1 Expired
NCI E-051-1994-2-FR-14 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 FR EP 95906686.1 Expired
NCI E-051-1994-2-ES-13 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 ES EP 95906686.1 Expired
NCI E-051-1994-2-MC-18 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 MC EP 95906686.1 Expired
NCI E-051-1994-2-PT-20 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 PT EP 95906686.1 Expired
NCI E-051-1994-2-NL-19 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 NL EP 95906686.1 Expired
NCI E-051-1994-2-IT-17 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 IT EP 95906686.1 Expired
NCI E-051-1994-2-IE-16 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 IE EP 95906686.1 Expired
NCI E-051-1994-2-GB-15 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 GB EP 95906686.1 Expired
NCI E-051-1994-2-CH-11 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 CH EP 95906686.1 Expired
NCI E-051-1994-2-AU-02 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 AU National Stage 15168/95 Expired
NCI E-051-1994-1-US-01 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 US CIP 08/360,923 5674492 Expired PDF
NCI E-051-1994-2-NO-06 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 NO National Stage 962526 Expired
NCI E-051-1994-2-PCT-01 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 PCT PCT COMB PCT/US1994/014767 Expired
NHLBI E-189-1989-3-US-03 GENE THERAPY US CON 08/361,198 Abandoned
NCI E-051-1994-2-JP-05 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 JP National Stage 1995-517593 Abandoned
NCI E-261-2008-1-EP-01 Melanoma Associated Antigenic Polypeptide, Epitopes Thereof And Vaccines Against Melanoma EP ORD 94203709.4 Abandoned
NCI E-051-1994-2-CA-03 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 CA National Stage 2179196 Abandoned
NCI E-157-1993-1-MX-09 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE MX National Stage 9409706 Abandoned
NCI E-157-1993-1-NL-23 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE NL EP 95909917.7 Abandoned
NCI E-157-1993-1-ES-25 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE ES EP 95909917.7 Abandoned
NCI E-157-1993-1-PT-24 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE PT EP 95909917.7 Abandoned
NCI E-157-1993-1-MC-22 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE MC EP 95909917.7 Abandoned
NCI E-157-1993-1-LU-21 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE LU EP 95909917.7 Abandoned
NCI E-157-1993-1-GB-28 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE GB EP 95909917.7 Abandoned
NCI E-157-1993-1-SE-26 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE SE EP 95909917.7 Abandoned